Tharimmune Leadership Signals Strong Outlook with Major Insider Purchase
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Insider Trading Alert: Sireesh Appajosyula, Chief Executive Officer and Director of Tharimmune (THAR), has increased their position through two separate purchase transactions on June 20, 2025:
- First purchase: 60,806 shares at $1.48 per share
- Second purchase: 690 shares at $1.42 per share
Following these transactions, Appajosyula directly owns 64,868 shares of Tharimmune common stock. The insider's decision to purchase shares on the open market could signal confidence in the company's future prospects. These purchases were reported via Form 4 within the required timeline, demonstrating compliance with SEC disclosure requirements.
Positive
- CEO Sireesh Appajosyula made significant open market purchases totaling 61,496 shares at an average price of ~$1.48, demonstrating strong insider confidence
Negative
- None.
Insider Trade Summary
Net Buyer: 61,496 shares ($90,973)
Net Buy
2 txns
Insider
Appajosyula Sireesh
Role
Chief Executive Officer
Bought
61,496 shs ($91K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 60,806 | $1.48 | $90K |
| Purchase | Common Stock | 690 | $1.42 | $979.80 |
Holdings After Transaction:
Common Stock — 64,178 shares (Direct)
Footnotes (1)
FAQ
What is the total value of THAR stock purchased by CEO Appajosyula in this Form 4 filing?
The total value of the stock purchase was approximately $90,971, calculated from 60,806 shares at $1.48 ($89,993) plus 690 shares at $1.42 ($978).
What positions does Sireesh Appajosyula hold at THAR?
According to the Form 4 filing, Sireesh Appajosyula serves as both the Chief Executive Officer and Director of Tharimmune, Inc. (THAR).
Was this THAR insider purchase made under a 10b5-1 trading plan?
No, the Form 4 filing does not indicate that this purchase was made pursuant to a 10b5-1 trading plan, as the corresponding checkbox was not marked on the form.